Drug Shortage Report for MYOCHRYSINE

Last updated on 2019-06-10 History
Report ID 45370
Drug Identification Number 01927620
Brand name MYOCHRYSINE
Common or Proper name MYOCHRYSINE 10MG/ML LJ AMP5
Company Name SANOFI-AVENTIS CANADA INC
Active Ingredient(s) GOLD SODIUM THIOMALATE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR
Packaging size 5 AMPOULES
ATC code M01CB
ATC description SPECIFIC ANTIRHEUMATIC AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2018-04-04
Actual start date 2018-04-04
Estimated end date 2019-09-30
Actual end date 2019-06-04
Shortage status Resolved
Updated date 2019-06-10
Company comments The continued global shortage of Myochrysine is due to manufacturing issues with the active ingredient. Consequently Sanofi has decided to discontinue all three strengths of Myochrysine globally.
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v33 2019-06-10 French Compare
v32 2019-06-10 English Compare
v31 2019-06-10 English Compare
v30 2019-06-10 French Compare
v29 2019-06-10 English Compare
v28 2018-09-07 French Compare
v27 2018-09-07 English Compare
v26 2018-08-02 French Compare
v25 2018-08-02 English Compare
v24 2018-07-31 English Compare
v23 2018-06-14 French Compare
v22 2018-06-14 English Compare
v21 2018-06-14 French Compare
v20 2018-06-14 English Compare
v19 2018-06-13 English Compare
v18 2018-06-12 French Compare
v17 2018-06-12 French Compare
v16 2018-06-12 English Compare
v15 2018-06-12 French Compare
v14 2018-06-12 English Compare

Showing 1 to 20 of 33